Revolutionizing Leukemia Care: Biostate AI Partners with Weill Cornell Medicine for Groundbreaking AI Models#United_States#New_York#AML#Weill_Cornell_Medicine#Biostate_AI
Revolutionizing Leukemia Care: Biostate AI Partners with Weill Cornell Medicine for Groundbreaking AI Models
Biostate AI is collaborating with Weill Cornell Medicine to create AI-driven models that personalize leukemia prognosis and treatment selection for patients, promising improved outcomes in care.
third-news.com
April 22, 2025 at 2:29 PM
Revolutionizing Leukemia Care: Biostate AI Partners with Weill Cornell Medicine for Groundbreaking AI Models#United_States#New_York#AML#Weill_Cornell_Medicine#Biostate_AI
New Study Validates Oral Immunotherapy for Food Allergies in Clinical Settings#United_States#San_Diego#Food_Allergy_Care#Oral_Immunotherapy#Weill_Cornell_Medicine
New Study Validates Oral Immunotherapy for Food Allergies in Clinical Settings
A recent study led by Weill Cornell Medicine reveals that oral immunotherapy (OIT) can be effectively and safely implemented in treating food allergies, achieving a remarkable 91% success rate.
third-news.com
February 27, 2025 at 3:40 PM
New Study Validates Oral Immunotherapy for Food Allergies in Clinical Settings#United_States#San_Diego#Food_Allergy_Care#Oral_Immunotherapy#Weill_Cornell_Medicine